Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Contact allergy to SIDAPA baseline series allergens in patients with eyelid dermatitis: An Italian multicentre study.
Stingeni L, Foti C, Guarneri F, Corazza M, Cristaudo A, Ferrucci SM, Gallo R, Martina E, Musumeci ML, Napolitano M, Nettis E, Patruno C, Pigatto PD, Piras V, Schena D, Casciola G, Antonelli E, Hansel K; SIDAPA Study Group. Stingeni L, et al. Among authors: martina e. Contact Dermatitis. 2024 May;90(5):479-485. doi: 10.1111/cod.14507. Epub 2024 Jan 24. Contact Dermatitis. 2024. PMID: 38268123
Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial.
Campanati A, Giuliodori K, Martina E, Giuliano A, Ganzetti G, Offidani A. Campanati A, et al. Among authors: martina e. J Neural Transm (Vienna). 2014 Jan;121(1):21-6. doi: 10.1007/s00702-013-1074-1. Epub 2013 Sep 20. J Neural Transm (Vienna). 2014. PMID: 24052109 Clinical Trial.
Photoprotection and photodermatitis: a case.
Martina E, Rosa L, Postacchini V, Simonetti O, Cataldi I, Offidani A. Martina E, et al. Contact Dermatitis. 2017 Jan;76(1):54-55. doi: 10.1111/cod.12644. Contact Dermatitis. 2017. PMID: 27957757 No abstract available.
Botulinum Toxin Off-Label Use in Dermatology: A Review.
Campanati A, Martina E, Giuliodori K, Consales V, Bobyr I, Offidani A. Campanati A, et al. Among authors: martina e. Skin Appendage Disord. 2017 Mar;3(1):39-56. doi: 10.1159/000452341. Epub 2017 Feb 1. Skin Appendage Disord. 2017. PMID: 28612001 Free PMC article. Review.
Omalizumab in Chronic Urticaria: An Italian Survey.
Damiani G, Diani M, Conic RRZ, Colli L, Ferrucci S, Martina E, Offidani AM, Pigatto PDM. Damiani G, et al. Among authors: martina e. Int Arch Allergy Immunol. 2019;178(1):45-49. doi: 10.1159/000492532. Epub 2018 Nov 5. Int Arch Allergy Immunol. 2019. PMID: 30396176
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients.
Marzano AV, Genovese G, Casazza G, Fierro MT, Dapavo P, Crimi N, Ferrucci S, Pepe P, Liberati S, Pigatto PD, Offidani A, Martina E, Girolomoni G, Rovaris M, Foti C, Stingeni L, Cristaudo A, Canonica GW, Nettis E, Asero R. Marzano AV, et al. Among authors: martina e. J Eur Acad Dermatol Venereol. 2019 May;33(5):918-924. doi: 10.1111/jdv.15350. Epub 2018 Dec 7. J Eur Acad Dermatol Venereol. 2019. PMID: 30451325 Free article.
83 results